发明名称 |
Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
摘要 |
The subject invention provides a pharmaceutical composition comprising an aqueous carrier; from 0.1 mg/ml to 20 mg/ml of the composition of a pharmaceutically acceptable salt of a peptide having the structural formula <?in-line-formulae description="In-line Formulae" end="lead"?><SMALLCAPS>NH</SMALLCAPS><SUB>2</SUB>-Gly Tyr Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Glu Glu Trp Ile Gly-<SMALLCAPS>COOH</SMALLCAPS>;<?in-line-formulae description="In-line Formulae" end="tail"?> and a substituted beta-cyclodextrin in an amount effective to dissolve the peptide in the aqueous carrier, wherein the composition has a pH between 4 and 9, a process for preparation, and a method of alleviating symptoms of systemic lupus erythematosus (SLE) in a human subject comprising administering to the human subject the pharmaceutical composition. |
申请公布号 |
ZA200506205(B) |
申请公布日期 |
2006.12.27 |
申请号 |
ZA20050006205 |
申请日期 |
2005.08.03 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
COHEN-VERED, SHARON;NAFTALI, ESMIRA;WEINSTEIN, VERA;GILBERT, ADRIAN;KLINGER, ETY |
分类号 |
A61K;A61K9/00;A61K9/19;A61K31/724;A61K38/00;A61K38/10;A61K39/00;A61K39/38;A61K47/40;A61K47/48;A61K51/10 |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|